메뉴 건너뛰기




Volumn 5, Issue 11, 2009, Pages 1262-1270

Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: The Three Musketeers or just another quixotic combination?

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR;

EID: 70349976708     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/b911313b     Document Type: Article
Times cited : (66)

References (88)
  • 34
    • 0024416085 scopus 로고
    • National Institutes of Health Clinical Trials Database. A randomized, double-blind, phase 3 trial comparing ipilimumab vs. placebo following radiotherapy in subjects with castration resistant prostate cancer that have received prior treatment with docetaxel. Available from:
    • T. Okawa M. Kita T. Arai K. Iida T. Dokiya Y. Takegawa Y. Hirokawa K. Yamazaki S. Hashimoto Cancer 1989 64 1769 1776
    • (1989) Cancer , vol.64 , pp. 1769-1776
    • Okawa, T.1    Kita, M.2    Arai, T.3    Iida, K.4    Dokiya, T.5    Takegawa, Y.6    Hirokawa, Y.7    Yamazaki, K.8    Hashimoto, S.9
  • 68
    • 11844254414 scopus 로고    scopus 로고
    • R. K. Jain Science 2005 307 58 62
    • (2005) Science , vol.307 , pp. 58-62
    • Jain, R.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.